A 62-year-old with HFrEF (EF 28%) on lisinopril and metoprolol remains NYHA II. Creatinine 1.0 mg/dL, potassium 4.5 mEq/L, BP 118/72 mm Hg, A1c 6.9%. According to current guidelines, which additional therapy most strongly reduces HF hospitalizations and CV death regardless of diabetes status?